Hubei Jumpcan Pharmaceutical Co., LtdSSE: 600566

Announcement on Receipt of Drug Registration Application Acceptance Notice

· Issued by Hubei Jumpcan Pharmaceutical Co., Ltd via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

The notice indicates that the product is entering the review stage for domestic production registration.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Receipt of Drug Registration Application Acceptance Notice

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Hubei Jumpcan Pharmaceutical Co., Ltd on 6ix

Earlier from Hubei Jumpcan Pharmaceutical

Later from Hubei Jumpcan Pharmaceutical

All Hubei Jumpcan Pharmaceutical news releases